Aortic valve stenosis and lipid-lowering therapy: the state of the art

I Bonadei1, E Vizzardi, A D'aloia

  • 1Section of Cardiovascular Diseases, Department of Experimental and Applied Medicine,, University of Study of Brescia, Brescia, Italy - enrico.vizzardi@tin.it.

Panminerva Medica
|January 18, 2014
PubMed

Insights

Statins show promise for treating aortic valve stenosis (AS), a common heart valve disease. Research suggests AS shares mechanisms with atherosclerosis, making statins a potential therapeutic option.

Area of Science:

  • Cardiology
  • Biomedical research
  • Pharmacology

Background:

  • Aortic valve stenosis (AS) is the most prevalent native valve disease.
  • Calcification of the trileaflet aortic valve is the primary cause of AS in Western countries.
  • Emerging evidence links valve calcification mechanisms to those of atherosclerosis.

Purpose of the Study:

  • To review and analyze current research on aortic valve stenosis.
  • To explore the potential of anti-atherosclerosis medications in treating AS.
  • To discuss the rationale for using statins in patients with AS.

Main Methods:

  • Systematic review of contemporary studies.
  • Analysis of evidence linking atherosclerosis and aortic valve calcification.
  • Evaluation of the pleiotropic effects of statins.

Main Results:

  • Atherosclerosis and aortic valve calcification share common underlying mechanisms.
  • Statins possess pleiotropic effects beneficial for cardiovascular health.
  • Contemporary studies suggest potential efficacy of statins in AS therapy.

Conclusions:

  • The shared pathophysiology between AS and atherosclerosis supports investigating anti-atherosclerosis drugs.
  • Statins are a promising therapeutic candidate for aortic valve stenosis due to their multifaceted benefits.
  • Further research is warranted to confirm the efficacy of statins in managing AS populations.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
611